Sequential Analysis of Neutrophil-To-Lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib
In Vivo - Greece
doi 10.21873/invivo.11828
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Anticancer Research USA Inc.